Tomasz Porazko

Dr. Tomasz Porazko

Department of Internal Medicine and Nephrology, Institute of Medical Sciences, University of Opole
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2008 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
TPTomasz Porazko
Tomasz Porazko
JKJakub Kuźniar
Jakub Kuźniar
MKMariusz Kusztal
Mariusz Kusztal
TKTomasz J. Kuźniar
Tomasz J. Kuźniar
WWWacław Weyde
Wacław Weyde
MKMarian Klinger
Marian Klinger
Background. The role of interleukin (IL)-6 and IL-18 in induction of the inflammatory reaction underlying arteriosclerosis, and protective effect of an anti-inflammatory cytokine IL-10 in this process, have been confirmed by experimental and clinical observations. A systemic inflammatory reaction marker, C-reactive protein (CRP), is known to be associated with the induction of IL-6 and IL-18 release. The chronic inflammatory state associated with renal insufficiency contributes to acceleration of arteriosclerosis, reflected by decreased elasticity which can be measured with aortal pulse wave velocity (PWV). It is well known that chronic kidney disease (CKD) is associated with the chronic inflammatory process, as evidenced by increase in CRP and IL-6 level. It also results in a drop of fetuin-A concentration which is the calcification inhibitor negatively regulated by inflammation. Part of the derangements associated with the progressive renal failure is also the rise of activated monocyte pool, which among others produces IL-18. The aim of the present study was to evaluate, through measurements of CRP, fetuin-A and aortal pulse wave velocity (aoPWV), whether IL-6 and IL-18 affect the arterial wall of CKD patients as a part of general inflammatory process or locally, through their effect on the arterial lesion development. Materials and methods. The study was performed in a group of 102 patients with stage V CKD (73 treated with haemodialysis and 29 treated with continuous ambulatory peritoneal dialysis) (CKD5 group) and in 30 healthy controls. We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium–phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone). ECG-gated carotid and femoral artery waveforms were recorded and analysed. Results. Serum levels of hs-CRP, IL-6, IL-10 and IL-18 were higher and fetuin-A levels were lower in the CKD5 group than in controls [6.4 (0.6–22.3) mg/dl versus 2.5 (0.5–5.2) mg/dl; 8.29 pg/ml (0.96–74.48)] versus 2.78 (7.91–0.77) pg/ml; 6.5 (3.7–29.7) pg/ml versus 4.1 (3.8–7.2) pg/ml; 254.4 (468.8–47.5) pg/ml versus 89.3 (91.3–27.5) pg/ml]. The aoPWV was higher in the CKD5 group patients than in the control group (9.4 ± 1.75 m/s versus 7.76 ± 1.67 m/s; P < 0.05, respectively). Serum fetuin-A level was negatively associated with hs-CRP and IL-6 but not with IL-18 or IL-10. The aoPWV positively correlated with hs-CRP ( r = 0.246; P < 0.05), IL-6 and IL-18 ( r = 0.220; P < 0.05) and negatively correlated with fetuin-A ( r = −0.204; P < 0.05). No relationship between IL-10 and aoPWV was found. In a multiple regression analysis model respecting inflammatory markers the influence of hs-CRP, IL-18 and fetuin-A on aoPWV remained significant. Conclusions. The novel observations in the present study are the data indicating that the distinctive contribution of IL-18, but not IL-6, to the arteriosclerosis occurrence in CKD patients, is independent from CRP, fetuin A or other factors involved in the general inflammatory process.

8 January 2007 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
WWW. Weyde
W. Weyde
MKMagdalena Krajewska
Magdalena Krajewska
WLW. Letachowicz
W. Letachowicz
TPTomasz Porazko
Tomasz Porazko
EWE. Watorek
E. Watorek
MKM. Klinger
M. Klinger
Obesity, which is often associated with diabetes, is increasingly encountered in the haemodialysed population, and this may produce difficulty in autogenous arteriovenous fistula creation. Prosthetic angioaccess or catheters, when used in place of autogenous fistulas, increase thrombotic and infectious complications in these already challenged patients. This prospective study was undertaken to assess the feasibility of autogenous arteriovenous fistula creation in 71 obese patients (BMI 34.6 +/- 7.8). We performed a two-stage procedure, in which radio-cephalic fistula formation was followed by subcutaneous transposition of the venous component for safe and easy puncture. Fistulas suitable for puncture, having blood flows of 799 +/- 285 ml/min, and sufficient to perform adequate haemodialysis (Kt/V 1.24) were achieved in 85% of the patients. Primary patency rates were 65% and 59% at 6 and 12 months, respectively, and secondary patency rates were 83% both at 6 and 12 months. Obesity does not prevent successful autogenous arteriovenous fistula formation, and may protect forearm venous vessels from the iatrogenic damage that occurs before the onset of haemodialysis therapy.

1 February 2006 in Blood Purification
Verified
Journal Article
Closed access
WWW. Weyde
W. Weyde
WLW. Letachowicz
W. Letachowicz
MKMariusz Kusztal
Mariusz Kusztal
TPTomasz Porazko
Tomasz Porazko
MKMagdalena Krajewska
Magdalena Krajewska
MKM. Klinger
M. Klinger
Background: There are controversies regarding the feasibility of autogenous vascular access creation in elderly hemodialysis (HD) patients. The aim of this retrospective study was to evaluate the results of creating different types of autogenous arteriovenous fistulas (AVFs) in a consecutive series of HD patients over 75 years of age. Methods: The analysis was performed in 131 patients (65 females, 66 males, average age 79.1 ± 3.6 years) in whom the creation of an autogenous AVF was considered within a 6-year period (February 1998 to February 2004). Among them, 26.7%were diabetics, 66.3% had hypertension, 30.7% were smokers, and 35.6% were obese. Patient survival and primary and secondary AVF patency were assessed. Results: The survival rates for patients were 94, 88, 66, and 45% at 6 months and at 1, 3, and 5 years, respectively. Successful autogenous AVF formation was finally achieved in 107 patients (81.6%): in 99 patients in the forearm and in 8in the upper arm. A Kaplan-Meier analysis showed primary AVF patency rates of: 74 ± 4.3% (± SE) at 1 month; 70 ± 4.7% at 6 months; 59 ± 4.9% at 1 year; 59 ± 4.9% at 2 years; 59± 4.9% at 3 years; 59 ± 4.9% at 4 years, and 58 ± 4.9% at 5 years. The secondary patency rates were: 95 ± 2.0; 92 ± 2.2; 84 ± 3.3; 79 ± 4.0; 72 ± 4.3; 71 ± 4.4, and 69 ± 4.5% in the corresponding periods, respectively. All postoperative complications in 10 patients were treated surgically, if applicable, without endovascular techniques. Conclusions: By exploiting all suitable types of autogenous AVF it is possible to establish the best form of vascular access even in the majority of elderly patients.

1 June 2007 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
WWWaclaw Weyde
Waclaw Weyde
MKMariusz Kusztal
Mariusz Kusztal
MKMagdalena Krajewska
Magdalena Krajewska
WLWaldemar Letachowicz
Waldemar Letachowicz
EWEwa Watorek
Ewa Watorek
MKMarian Klinger
Marian Klinger

12 June 2024 in IEEE Access
Verified
Journal Article
Open access
Dawid PawuśDawid Pawuś
Dawid Pawuś
TPTomasz Porazko
Tomasz Porazko
Szczepan PaszkielSzczepan Paszkiel
Szczepan Paszkiel
This study explores the contemporary landscape of integrating numerical algorithms, artificial intelligence (AI), and expert methodologies within the domain of nephrology. Focusing on automation and decision support, we scrutinize the impact of numerical algorithms on the precise evaluation of kidney function. Furthermore, we delve into the transformative potential of artificial intelligence, particularly in the realms of machine learning and deep learning applications, elucidating its role in early disease detection and the formulation of personalized treatment strategies. The synergy between computer-based tools and expert-driven approaches is examined, underscoring their collaborative role in enhancing the accuracy and dependability of diagnoses. Additionally, we address the ethical considerations and challenges associated with the incorporation of automation in nephrology. The paper provides a concise overview of in-depth analysis while illustrating the promising prospects of these innovative methodologies for reshaping nephrology research and patient care.

1 January 2008 in Journal of Renal Nutrition
Verified
Journal Article
Closed access
JKJakub Kuźniar
Jakub Kuźniar
TPTomasz Porazko
Tomasz Porazko
MKMarian Klinger
Marian Klinger